MSJSX
Price
$16.82
Change
+$0.04 (+0.24%)
Updated
Dec 20 closing price
SFCWX
Price
$69.39
Change
-$0.28 (-0.40%)
Updated
Dec 20 closing price
Ad is loading...

MSJSX vs SFCWX

Header iconMSJSX vs SFCWX Comparison
Open Charts MSJSX vs SFCWXBanner chart's image
Morgan Stanley Global Endurance R6
Price$16.82
Change+$0.04 (+0.24%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World F3
Price$69.39
Change-$0.28 (-0.40%)
VolumeN/A
CapitalizationN/A
MSJSX vs SFCWX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSJSX vs. SFCWX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSJSX is a Hold and SFCWX is a Buy.

FUNDAMENTALS
Fundamentals
SFCWX has more cash in the bank: 73.6B vs. MSJSX (28.1M). MSJSX pays higher dividends than SFCWX: MSJSX (1.78) vs SFCWX (0.95). MSJSX was incepted earlier than SFCWX: MSJSX (6 years) vs SFCWX (8 years). MSJSX is a more actively managed with annual turnover of: 130.00 vs. SFCWX (29.00). SFCWX has a lower initial minimum investment than MSJSX: SFCWX (1000000) vs MSJSX (5000000). MSJSX annual gain was more profitable for investors over the last year : 6.23 vs. SFCWX (4.67). MSJSX return over 5 years is better than : 33.12 vs. SFCWX (14.96).
MSJSXSFCWXMSJSX / SFCWX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years8 years-
Gain YTD6.5013.494186%
Front LoadN/AN/A-
Min. Initial Investment50000001000000500%
Min. Initial Investment IRAN/AN/A-
Net Assets28.1M73.6B0%
Annual Yield % from dividends1.780.95187%
Returns for 1 year6.234.67133%
Returns for 3 years-38.45-11.01349%
Returns for 5 years33.1214.96221%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMRC36.920.67
+1.85%
Digimarc Corp
DNLI21.45-0.04
-0.19%
Denali Therapeutics
AIM0.19N/A
-0.58%
AIM ImmunoTech
LYEL0.61-0.03
-4.41%
Lyell Immunopharma
XPO135.25-10.26
-7.05%
XPO